Neogen Corporation (NEOG) fair value analysis

Nasdaq · Updated 2026-09-07

Neogen Corporation is a food and animal safety company that develops and manufactures testing and detection products for pathogens, allergens, and other contaminants in food and animal feed. The company operates globally across multiple continents, serving food producers, processors, and animal agriculture operations worldwide.

Forward Fair Value verdict

Fairly valued

Based on TickrTrends' weekly Forward Fair Value model, NEOG is trading at within about 10% of estimated fair value.

NEOG currently ranks #73 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.

Last price: $11.90
Sector: Healthcare
12-month range: $5.80–$11.90

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: F
Leverage: Low
Margin trend: Contracting
Revenue growth: Declining
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The top quarter of its range

What our data shows for NEOG

Our model validated 17 trailing price-to-earnings windows for NEOG, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $5.80–$11.90.
The 14-day relative strength index sits at a neutral 56.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for NEOG
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent NEOG news

TickrTrends' derived news-sentiment signal for NEOG is currently leaning positive, computed from recent coverage.

Neogen Corporation 2026 Q4 - Results - Earnings Call Presentation (NASDAQ:NEOG) 2026-07-31 (seekingalpha.com, 2026-07-31)
TickrTrends take: Neogen Corporation reported its 2026 Q4 results, with the company currently assessed as fairly valued according to TickrTrends metrics within the Healthcare sector. For valuation-focused investors, the key consideration is whether the company's earnings trajectory and operational performance in this earnings period support the current fair value assessment or signal potential changes to that positioning. Given the fair value designation, readers should monitor whether management commentary indicates growth acceleration or headwinds that might warrant valuation recalibration in future periods.
Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript (seekingalpha.com, 2026-07-30)
TickrTrends take: Neogen Corporation's Q4 2026 earnings call provides investors with recent operating performance data that can be evaluated against its current fairly valued status on TickrTrends. For valuation-focused readers, the earnings transcript offers concrete information about revenue trends, margin performance, and capital allocation decisions that would support or challenge the fairly valued assessment. Monitoring management commentary on market demand within the Healthcare sector and guidance for future periods will be key to determining whether the current valuation accurately reflects the company's near-term prospects.

What people are saying

Follow the NEOG conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — TickrTrends' derived indicators for NEOG showed a shift this week as the momentum indicator downgraded from an A rating to none. The stock remains in the Healthcare sector and maintains a Fairly valued assessment according to current valuation metrics.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is NEOG stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), NEOG is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.

What is NEOG's TickrTrends verdict?

NEOG's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.

How does NEOG compare to other Healthcare stocks?

NEOG ranks #73 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is NEOG overbought or oversold?

NEOG's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

NEOG vs ACHC · NEOG vs AZTA · NEOG vs COR · NEOG vs ELV · NEOG vs HCSG